Skip to main content
Addgene

pCdOpt-BMX
(Plasmid #203929)

Ordering

This material is available to academics and nonprofits only.
Item Catalog # Description Quantity Price (USD)
Plasmid 203929 Standard format: Plasmid sent in bacteria as agar stab 1 $85

Backbone

  • Vector backbone
    pUCIDT
  • Backbone size w/o insert (bp) 2752
  • Total vector size (bp) 2752
  • Vector type
    Yeast Expression
  • Selectable markers
    Zeocin

Growth in Bacteria

  • Bacterial Resistance(s)
    Ampicillin, 100 μg/mL
  • Growth Temperature
    37°C
  • Growth Strain(s)
    DH5alpha
  • Copy number
    Unknown

Gene/Insert

  • Gene/Insert name
    BleMX
  • Species
    Streptoalloteichus hindustanus
  • Insert Size (bp)
    922
  • Mutation
    BleMX was codon optimized for Candida albicans or other CTG clade Candida species

Cloning Information

Resource Information

  • Supplemental Documents
  • A portion of this plasmid was derived from a plasmid made by
    Codon Optimized BleMX was gene synthesized by IDT and generated by inserting in pUCIDT vector.
  • Article Citing this Plasmid

Terms and Licenses

  • Academic/Nonprofit Terms
  • Industry Terms
    • Not Available to Industry
Trademarks:
  • Zeocin® is an InvivoGen trademark.

Depositor Comments

The BleMX is codon optimized for Candida albicans and the TEF1 promoter and TEF1 terminator is used for expression in yeast.

How to cite this plasmid ( Back to top)

These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.

  • For your Materials & Methods section:

    pCdOpt-BMX was a gift from Scott Briggs (Addgene plasmid # 203929 ; http://n2t.net/addgene:203929 ; RRID:Addgene_203929)
  • For your References section:

    An expanded toolkit of drug resistance cassettes for Candida glabrata, Candida auris, and Candida albicans leads to new insights into the ergosterol pathway. Gregor JB, Gutierrez-Schultz VA, Hoda S, Baker KM, Saha D, Burghaze MG, Vazquez C, Burgei KE, Briggs SD. mSphere. 2023 Nov 6:e0031123. doi: 10.1128/msphere.00311-23. 10.1128/msphere.00311-23 PubMed 37929964